When taking milk thistle or any new supplement, it can take some time before noticing any improvements
Current clinical evidence suggests GLP-1 receptor agonists like semaglutide have limited passage into breast milk, yet many lactating women remain uncertain about whether these medications are truly safe for their nursing infants
When to stop treatment or seek urgent advice : Severe or persistent abdominal pain Significant increase in diarrhoea frequency or blood in stools Signs of dehydration (reduced urine output, dizziness, dry mouth) Symptoms suggesting Crohn's flare (fever, weight loss beyond expected, severe fatigue) Inability to tolerate oral intake due to nausea or vomiting Right upper quadrant pain, jaundice or fever (possible gallbladder disease) Patients should have direct access to their gastroenterology team and clear instructions on when to seek urgent medical review
Explore full compound insights: Related Research Resources Disclaimer The statements made regarding this product have not been evaluated by regulatory authorities
In 2026, the global market for GLP-1 Meal Replacement Market is estimated at USD 2.4 billion
The oral tablet is taken once daily on an empty stomach, as directed